Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
| Fund/benchmark | Change | |
|---|---|---|
| Price | Crystal Amber Fund Limited (Ordinary Share) | +67.38% |
| NAV | Crystal Amber Fund Limited (Ordinary Share) | +57.73% |
| Morningstar's Benchmark | Numis Smaller Companies TR GBP | +20.62% |
- Final Results
- Result of Extraordinary General Meeting
- Proposed B share scheme and notice of GM
- Monthly Net Asset Value
- Total Voting Rights
- Holding(s) in Company
- Transaction in Own Shares and Total Voting Rights
- Director/PDMR Shareholding
- Extension to Share Buyback Programme
- Investee company update: Morphic Medical Inc.
More ▼
Key statistics
On Tuesday, Crystal Amber Fund Limited (CRS:LSE) closed at 109.50, -9.37% below its 52-week high of 120.82, set on Oct 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Shares outstanding | 71.55m |
|---|---|
| Market cap | 74.41m GBP |
| Total assets | 122.67m GBP |
| Total expense ratio | 1.53% |
| High | 114.00 |
| Low | 109.50 |
| Previous close | 104.00 |
| Average volume | 18.14k |
|---|---|
| YTD Change | +42.21% |
| Beta | 1.4885 |
| Diluted NAV (est) | 171.49 |
| Diluted NAV (last pub) | 169.41 |
| Premium/Discount | -35.59% |
| Net Gearing | 0.00% |
| Annual div (ADY) | -- |
|---|---|
| Annual div yield (ADY) | -- |
| Div ex-date | Jun 15 2023 |
| Div pay-date | Jul 07 2023 |
Data delayed at least 20 minutes, as of Nov 12 2024 16:27 GMT.
More ▼
